Erasca, Inc. announces positive Phase 1 data for ERAS-0015 and expedites Phase 3 trial for pancreatic cancer, signaling growth potential in the biotech sector.
| Name | Erasca, Inc. |
|---|---|
| CIK | 0001761918 |
| Tickers | ERAS |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | <br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 831217027 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (858) 465-6511 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Erasca, Inc. announces positive Phase 1 data for ERAS-0015 and expedites Phase 3 trial for pancreatic cancer, signaling growth potential in the biotech sector.
Erasca, Inc. releases its Q3 2026 results, showcasing financial updates and operational insights in the pharmaceutical preparations sector.
Erasca, Inc. announces its financial results for Q3 2026, shedding light on its performance in the pharmaceutical preparations sector.
Erasca, Inc. is restructuring its leadership team, terminating COO Nik Chetwyn as part of a strategic realignment to enhance RAS-targeting program development.
358 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | 8-K | 8-K | 8.01 | 0001193125-26-469283 | 001-40602 | 261576669 | 34 | 246331 | 1 | 1 |
| 2026-11-16 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-074061 | 001-40602 | 261558355 | 33 | 6830 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001897612-26-000747 | 005-92728 | 261556559 | 34 | 7705 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493215-26-000188 | 005-92728 | 261555589 | 34 | 10329 | |||
| 2026-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-458350 | 001-40602 | 261546939 | 34 | 346244 | 1 | 1 |
| 2026-11-12 | 10-Q | 10-Q | 0001193125-26-458289 | 001-40602 | 261546722 | 34 | 23420873 | 1 | 1 | |
| 2026-10-16 | 8-K | 8-K | 5.02 | 0001193125-26-423433 | 001-40602 | 261464435 | 34 | 149957 | 1 | 1 |
| 2026-10-15 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-065966 | 001-40602 | 261462276 | 33 | 6983 | |||
| 2026-09-15 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-062070 | 001-40602 | 261381396 | 33 | 6983 | |||
| 2026-08-24 | 8-K | 8-K | 8.01 | 0001193125-26-361895 | 001-40602 | 261306390 | 34 | 155203 | 1 | 1 |
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-057296 | 001-40602 | 261286241 | 33 | 6286 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-352396 | 005-92728 | 261282446 | 34 | 10671 | |||
| 2026-08-12 | 4 | 4 | 0001193125-26-346924 | 6287 | ||||||
| 2026-08-12 | 3 | 3 | 0001193125-26-346920 | 3136 | ||||||
| 2026-08-11 | S-8 | S-8 | 0001193125-26-344845 | 333-298234 | 261263913 | 33 | 382171 | 1 | 1 | |
| 2026-08-11 | 10-Q | 10-Q | 0001193125-26-344611 | 001-40602 | 261263210 | 34 | 23043153 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-344584 | 001-40602 | 261263121 | 34 | 352332 | 1 | 1 |
| 2026-08-10 | 8-K | 8-K | 5.02 | 0001193125-26-342669 | 001-40602 | 261259522 | 34 | 164667 | 1 | 1 |
| 2026-07-21 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-048993 | 001-40602 | 261190234 | 33 | 6285 | |||
| 2026-07-14 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-303357 | 001-40602 | 261174918 | 34 | 499247 | 1 | 1 |
| 2026-07-14 | 424B5 | 424B5 | 0001193125-26-303352 | 333-297427 | 261174909 | 33 | 680906 | 1 | 1 | |
| 2026-07-13 | 424B5 | 424B5 | 0001193125-26-302148 | 333-297427 | 261172056 | 33 | 545687 | |||
| 2026-07-13 | 8-K | 8-K | 8.01 | 0001193125-26-302045 | 001-40602 | 261171532 | 34 | 174762 | 1 | 1 |
| 2026-07-13 | S-3ASR | S-3ASR | 0001193125-26-302035 | 333-297427 | 261171507 | 33 | 772650 | 1 | 1 | |
| 2026-07-01 | 8-K | 8-K | 5.07 | 0001193125-26-290881 | 001-40602 | 261141851 | 34 | 165007 | 1 | 1 |
| 2026-06-29 | 4 | 4 | 0001193125-26-288910 | 5378 | ||||||
| 2026-06-29 | 4 | 4 | 0001193125-26-288908 | 5309 | ||||||
| 2026-06-29 | 4 | 4 | 0001193125-26-288906 | 5382 | ||||||
| 2026-06-29 | 4 | 4 | 0001193125-26-288905 | 5371 | ||||||
| 2026-06-29 | 4 | 4 | 0001193125-26-288903 | 5378 | ||||||
| 2026-06-29 | 4 | 4 | 0001193125-26-288902 | 5375 | ||||||
| 2026-06-15 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-043327 | 001-40602 | 261092208 | 33 | 6983 | |||
| 2026-05-15 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-035691 | 001-40602 | 26989121 | 33 | 6979 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001738048-26-000060 | 005-92728 | 26988704 | 34 | 17871 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-062612 | 005-92728 | 26988206 | 34 | 12505 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001897612-26-000492 | 005-92728 | 26983416 | 34 | 7625 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493215-26-000106 | 005-92728 | 26982504 | 34 | 12539 | |||
| 2026-05-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-002900 | 005-92728 | 26970236 | 34 | 17265 | |||
| 2026-05-11 | 10-Q | 10-Q | 0001193125-26-216788 | 001-40602 | 26963351 | 34 | 17707024 | 1 | 1 | |
| 2026-05-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-216739 | 001-40602 | 26963124 | 34 | 297388 | 1 | 1 |
| 2026-04-28 | ARS | ARS | 0001193125-26-187422 | 001-40602 | 26908796 | 34 | 1984597 | |||
| 2026-04-28 | DEFA14A | DEFA14A | 0001193125-26-187382 | 001-40602 | 26908681 | 34 | 111818 | |||
| 2026-04-28 | DEF 14A | DEF 14A | 0001193125-26-187361 | 001-40602 | 26908662 | 34 | 1214943 | 1 | 1 | |
| 2026-04-27 | 8-K | 8-K | 8.01 | 0001193125-26-182137 | 001-40602 | 26901292 | 34 | 1303094 | 1 | 1 |
| 2026-04-27 | 8-K | 8-K | 7.01,8.01 | 0001193125-26-179214 | 001-40602 | 26896697 | 34 | 158428 | 1 | 1 |
| 2026-04-21 | 8-K | 8-K | 8.01 | 0001193125-26-165297 | 001-40602 | 26876928 | 34 | 151982 | 1 | 1 |
| 2026-04-15 | 144/A | xsl144X01/primary_doc.xml | 0001628280-26-025296 | 001-40602 | 26864949 | 33 | 7073 | |||
| 2026-04-15 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-025291 | 001-40602 | 26864844 | 33 | 6854 | |||
| 2026-04-03 | 4 | 4 | 0001193125-26-141395 | 8985 | ||||||
| 2026-04-01 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-022734 | 001-40602 | 26826980 | 33 | 4992 | |||
| 2026-03-16 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-018080 | 001-40602 | 26755993 | 33 | 6433 | |||
| 2026-03-12 | 10-K | 10-K | 0001193125-26-104150 | 001-40602 | 26747810 | 34 | 51996191 | 1 | 1 | |
| 2026-03-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-104105 | 001-40602 | 26747619 | 34 | 350700 | 1 | 1 |
| 2026-03-06 | 4 | 4 | 0001193125-26-095181 | 8865 | ||||||
| 2026-03-04 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-014764 | 001-40602 | 26722989 | 33 | 4332 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-008468 | 001-40602 | 26639747 | 33 | 6432 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-26-000279 | 005-92728 | 26637759 | 34 | 7509 | |||
| 2026-01-30 | 4 | 4 | 0001193125-26-030626 | 5389 | ||||||
| 2026-01-30 | 4 | 4 | 0001193125-26-030624 | 7051 | ||||||
| 2026-01-30 | 4 | 4 | 0001193125-26-030619 | 5327 | ||||||
| 2026-01-30 | 4 | 4 | 0001193125-26-030617 | 5281 | ||||||
| 2026-01-30 | 4 | 4 | 0001193125-26-030615 | 5319 | ||||||
| 2026-01-29 | 8-K | 8-K | 8.01 | 0001193125-26-029467 | 001-40602 | 26578536 | 34 | 155359 | 1 | 1 |
| 2026-01-22 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-019651 | 001-40602 | 26552460 | 34 | 486884 | 1 | 1 |
| 2026-01-22 | 424B5 | 424B5 | 0001193125-26-019641 | 333-289537 | 26552443 | 33 | 556955 | |||
| 2026-01-20 | 8-K | 8-K | 2.02 | 0001193125-26-016556 | 001-40602 | 26542837 | 34 | 142784 | 1 | 1 |
| 2026-01-20 | 424B5 | 424B5 | 0001193125-26-016549 | 333-289537 | 26542802 | 33 | 558728 | |||
| 2026-01-15 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-002131 | 001-40602 | 26535092 | 33 | 6432 | |||
| 2026-01-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-003756 | 005-92728 | 26533607 | 34 | 15928 | |||
| 2026-01-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-009820 | 001-40602 | 26524741 | 34 | 17947698 | 1 | 1 |
| 2026-01-08 | 4 | 4 | 0001193125-26-008076 | 10314 | ||||||
| 2026-01-07 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-001146 | 001-40602 | 26515582 | 33 | 4365 | |||
| 2026-01-05 | 4 | 4 | 0001193125-26-001611 | 5631 | ||||||
| 2026-01-05 | 4 | 4 | 0001193125-26-001610 | 5565 | ||||||
| 2026-01-05 | 4 | 4 | 0001193125-26-001609 | 5638 | ||||||
| 2026-01-05 | 4 | 4 | 0001193125-26-001608 | 5634 | ||||||
| 2026-01-05 | 4 | 4 | 0001193125-26-001606 | 5627 | ||||||
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0001628280-25-057210 | 001-40602 | 251573059 | 33 | 6431 | |||
| 2025-11-17 | 144 | xsl144X01/primary_doc.xml | 0001628280-25-052617 | 001-40602 | 251491383 | 33 | 6474 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000935836-25-000678 | 005-92728 | 251483785 | 34 | 15533 | |||
| 2025-11-12 | 10-Q | 10-Q | 0001193125-25-277625 | 001-40602 | 251472983 | 34 | 12667217 | 1 | 1 | |
| 2025-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-277571 | 001-40602 | 251472758 | 34 | 333709 | 1 | 1 |
| 2025-10-15 | 144 | xsl144X01/primary_doc.xml | 0001628280-25-045091 | 001-40602 | 251394769 | 33 | 6473 | |||
| 2025-09-15 | 144 | xsl144X01/primary_doc.xml | 0001973524-25-000005 | 001-40602 | 251314588 | 33 | 6473 | |||
| 2025-08-22 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002722 | 333-289537 | 251247801 | 33 | 1740 | ||
| 2025-08-20 | CORRESP | filename1.htm | 0001193125-25-184070 | 6714 | ||||||
| 2025-08-18 | UPLOAD | filename1.pdf | 0000000000-25-008699 | 333-289537 | 40121 | |||||
| 2025-08-15 | 144 | xsl144X01/primary_doc.xml | 0002007317-25-000883 | 001-40602 | 251224307 | 33 | 6450 | |||
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000935836-25-000535 | 005-92728 | 251220577 | 34 | 15301 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-021783 | 005-92728 | 251216825 | 34 | 35414 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-25-000379 | 005-92728 | 251216270 | 34 | 7510 | |||
| 2025-08-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-004725 | 005-92728 | 251213742 | 34 | 16925 | |||
| 2025-08-12 | S-3 | S-3 | 0001193125-25-179038 | 333-289537 | 251207475 | 33 | 1174544 | 1 | 1 | |
| 2025-08-12 | 10-Q | 10-Q | 0001193125-25-178996 | 001-40602 | 251207149 | 34 | 12691292 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-178950 | 001-40602 | 251206714 | 34 | 332007 | 1 | 1 |
| 2025-07-15 | 144 | xsl144X01/primary_doc.xml | 0002007317-25-000717 | 001-40602 | 251124630 | 33 | 6417 | |||
| 2025-06-26 | 8-K | 8-K | 5.07 | 0000950170-25-090493 | 001-40602 | 251081200 | 34 | 165268 | 1 | 1 |
| 2025-06-26 | 4 | 4 | 0000950170-25-090426 | 5219 | ||||||
| 2025-06-26 | 4 | 4 | 0000950170-25-090424 | 5152 | ||||||
| 2025-06-26 | 4 | 4 | 0000950170-25-090423 | 5221 | ||||||
| 2025-06-26 | 4 | 4 | 0000950170-25-090422 | 5221 | ||||||
| 2025-06-26 | 4 | 4 | 0000950170-25-090420 | 5225 | ||||||
| 2025-06-26 | 4 | 4 | 0000950170-25-090418 | 5218 | ||||||
| 2025-06-26 | 4 | 4 | 0000950170-25-090415 | 5214 | ||||||
| 2025-06-16 | 144 | xsl144X01/primary_doc.xml | 0002007317-25-000579 | 001-40602 | 251049790 | 33 | 6417 | |||
| 2025-06-03 | 4 | 4 | 0000950170-25-080941 | 6282 | ||||||
| 2025-05-15 | 144 | xsl144X01/primary_doc.xml | 0002007317-25-000398 | 001-40602 | 25953362 | 33 | 6415 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-012990 | 005-92728 | 25949408 | 34 | 57609 | |||
| 2025-05-13 | 10-Q | 10-Q | 0000950170-25-070418 | 001-40602 | 25940529 | 34 | 11363291 | 1 | 1 | |
| 2025-05-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-070336 | 001-40602 | 25940151 | 34 | 292152 | 1 | 1 |
| 2025-04-29 | ARS | ARS | 0001193125-25-103908 | 001-40602 | 25888291 | 34 | 11489169 | |||
| 2025-04-29 | DEFA14A | DEFA14A | 0001193125-25-103883 | 001-40602 | 25888180 | 34 | 179189 | |||
| 2025-04-29 | DEF 14A | DEF 14A | 0001193125-25-103868 | 001-40602 | 25888101 | 34 | 1324772 | 1 | 1 | |
| 2025-04-15 | 144 | xsl144X01/primary_doc.xml | 0001971857-25-000194 | 001-40602 | 25839393 | 33 | 6266 | |||
| 2025-03-20 | 10-K | 10-K | 0000950170-25-042682 | 001-40602 | 25756701 | 34 | 63480159 | 1 | 1 | |
| 2025-03-20 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-042659 | 001-40602 | 25756522 | 34 | 346699 | 1 | 1 |
| 2025-03-17 | 144 | xsl144X01/primary_doc.xml | 0002002698-25-000094 | 001-40602 | 25745184 | 33 | 6283 | |||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0002007317-25-000161 | 001-40602 | 25634688 | 33 | 6289 | |||
| 2025-02-18 | 4 | 4 | 0000950170-25-021831 | 5257 | ||||||
| 2025-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000919574-25-001292 | 005-92728 | 25622482 | 34 | 16886 | |||
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-012252 | 005-92728 | 25615863 | 34 | 45093 | |||
| 2025-02-05 | 4 | 4 | 0000950170-25-014197 | 8632 | ||||||
| 2025-02-05 | 4 | 4 | 0000950170-25-014195 | 5267 | ||||||
| 2025-02-05 | 4 | 4 | 0000950170-25-014194 | 8626 | ||||||
| 2025-02-05 | 4 | 4 | 0000950170-25-014192 | 5329 | ||||||
| 2025-01-15 | 144 | xsl144X01/primary_doc.xml | 0002007317-25-000008 | 001-40602 | 25532549 | 33 | 6284 | |||
| 2025-01-13 | 8-K | 8-K | 7.01,9.01 | 0000950170-25-004613 | 001-40602 | 25525070 | 34 | 28850266 | 1 | 1 |
| 2025-01-02 | 4 | 4 | 0000950170-25-000639 | 5612 | ||||||
| 2025-01-02 | 4 | 4 | 0000950170-25-000637 | 5550 | ||||||
| 2025-01-02 | 4 | 4 | 0000950170-25-000635 | 5619 | ||||||
| 2025-01-02 | 4 | 4 | 0000950170-25-000630 | 5616 | ||||||
| 2024-12-16 | 144 | xsl144X01/primary_doc.xml | 0001971857-24-000872 | 001-40602 | 241552815 | 33 | 6284 | |||
| 2024-11-15 | 144 | xsl144X01/primary_doc.xml | 0002007317-24-000632 | 001-40602 | 241467234 | 33 | 6284 | |||
| 2024-11-14 | SC 13G/A | ARCH VENTURE FUND X, L.P. - ERASCA, INC. -- SCH 13G/A(#1E) | 0001072613-24-000884 | 005-92728 | 241464239 | 34 | 80501 | |||
| 2024-11-14 | SC 13G/A | armistice-eras093024a1.htm | 0001172661-24-005163 | 005-92728 | 241461719 | 34 | 90578 | |||
| 2024-11-14 | SC 13G | eras13gsep24.txt | 0001897612-24-001982 | 005-92728 | 34 | 6456 | ||||
| 2024-11-12 | 10-Q | 10-Q | 0000950170-24-125481 | 001-40602 | 241448595 | 34 | 10040537 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-125337 | 001-40602 | 241447935 | 34 | 308013 | 1 | 1 |
| 2024-11-08 | SC 13G | us29479a1088_110824.txt | 0002012383-24-003610 | 005-92728 | 241439733 | 34 | 13679 | |||
| 2024-10-29 | SC 13G/A | SC 13G/A | 0001193125-24-246753 | 005-92728 | 241407122 | 34 | 73962 | |||
| 2024-10-24 | SC 13G | us29479a1088_102424.txt | 0002012383-24-002198 | 005-92728 | 241392075 | 34 | 13665 | |||
| 2024-10-24 | 8-K | 8-K | 8.01 | 0000950170-24-116856 | 001-40602 | 241390789 | 34 | 164627 | 1 | 1 |
| 2024-10-15 | 144 | xsl144X01/primary_doc.xml | 0001971857-24-000668 | 001-40602 | 241371358 | 33 | 6285 | |||
| 2024-09-16 | 144 | xsl144X01/primary_doc.xml | 0002002698-24-000426 | 001-40602 | 241301151 | 33 | 6285 | |||
| 2024-08-15 | 144 | xsl144X01/primary_doc.xml | 0002002698-24-000203 | 001-40602 | 241211452 | 33 | 6288 | |||
| 2024-08-12 | 10-Q | 10-Q | 0000950170-24-095437 | 001-40602 | 241196898 | 34 | 11191933 | 1 | 1 | |
| 2024-08-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-095408 | 001-40602 | 241196744 | 34 | 310013 | 1 | 1 |
| 2024-07-15 | 144 | xsl144X01/primary_doc.xml | 0001971857-24-000523 | 001-40602 | 241116688 | 33 | 6334 | |||
| 2024-06-24 | 8-K | 8-K | 5.07 | 0000950170-24-076476 | 001-40602 | 241062244 | 34 | 163958 | 1 | 1 |
| 2024-06-24 | 8-K | 8-K | 8.01 | 0000950170-24-076474 | 001-40602 | 241062234 | 34 | 156894 | 1 | 1 |
| 2024-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-24-005929 | 5454 | ||||||
| 2024-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-24-005928 | 5456 | ||||||
| 2024-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-24-005927 | 5387 | ||||||
| 2024-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-24-005926 | 5488 | ||||||
| 2024-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-24-005925 | 5496 | ||||||
| 2024-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-24-005924 | 5557 | ||||||
| 2024-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-24-005923 | 5491 | ||||||
| 2024-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-24-005922 | 5456 | ||||||
| 2024-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-24-005921 | 5449 | ||||||
| 2024-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-24-005920 | 5453 | ||||||
| 2024-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-24-005919 | 5460 | ||||||
| 2024-06-17 | 144 | xsl144X01/primary_doc.xml | 0001971857-24-000415 | 001-40602 | 241047884 | 33 | 6339 | |||
| 2024-05-31 | SC 13G | SC 13G | 0001104659-24-067180 | 005-92728 | 241009932 | 34 | 181797 | |||
| 2024-05-29 | SC 13G | SC 13G | 0001193125-24-148846 | 005-92728 | 24995837 | 34 | 333639 | |||
| 2024-05-28 | SC 13G | d11056386_13-g.htm | 0000919574-24-003350 | 005-92728 | 24992480 | 34 | 108777 | |||
| 2024-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-24-005689 | 5911 | ||||||
| 2024-05-17 | 424B5 | 424B5 | 0001193125-24-141858 | 333-266802 | 24961206 | 33 | 444469 | |||
| 2024-05-17 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-141066 | 001-40602 | 24957615 | 34 | 467909 | 1 | 1 |
| 2024-05-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-05-16 16:00:00 | 9999999995-24-001559 | 333-279261 | 24957588 | 33 | 1724 | ||
| 2024-05-16 | 8-K | 8-K | 1.01,2.05,8.01,9.01 | 0001193125-24-140591 | 001-40602 | 24955922 | 34 | 22085558 | 1 | 1 |
| 2024-05-15 | 144 | xsl144X01/primary_doc.xml | 0001971857-24-000225 | 001-40602 | 24949923 | 33 | 6329 | |||
| 2024-05-14 | CORRESP | filename1.htm | 0001193125-24-138188 | 6585 | ||||||
| 2024-05-14 | UPLOAD | filename1.pdf | 0000000000-24-005503 | 333-279261 | 40290 | |||||
| 2024-05-09 | S-3 | S-3 | 0001193125-24-135289 | 333-279261 | 24930980 | 33 | 276963 | |||
| 2024-05-09 | S-8 | S-8 | 0001193125-24-135276 | 333-279257 | 24930811 | 33 | 92566 | |||
| 2024-05-08 | 10-Q | 10-Q | 0000950170-24-055668 | 001-40602 | 24926208 | 34 | 8452190 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-055644 | 001-40602 | 24926048 | 34 | 271915 | 1 | 1 |
| 2024-04-26 | ARS | ARS | 0001193125-24-118113 | 001-40602 | 24884079 | 34 | 3688192 | |||
| 2024-04-26 | DEFA14A | DEFA14A | 0001193125-24-118067 | 001-40602 | 24883910 | 34 | 433190 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0001193125-24-117977 | 001-40602 | 24883596 | 34 | 711052 | |||
| 2024-04-15 | 144 | xsl144X01/primary_doc.xml | 0002002698-24-000109 | 001-40602 | 24843464 | 33 | 6335 | |||
| 2024-03-28 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-24-080630 | 001-40602 | 24799085 | 34 | 453528 | 1 | 1 |
| 2024-03-27 | 10-K | 10-K | 0000950170-24-037193 | 001-40602 | 24790795 | 34 | 50954615 | 1 | 1 | |
| 2024-03-27 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-037161 | 001-40602 | 24790571 | 34 | 310088 | 1 | 1 |
| 2024-03-15 | 144 | xsl144X01/primary_doc.xml | 0002007317-24-000423 | 001-40602 | 24753833 | 33 | 6300 | |||
| 2024-02-15 | 144 | xsl144X01/primary_doc.xml | 0002007317-24-000128 | 001-40602 | 24643232 | 33 | 6291 | |||
| 2024-02-14 | SC 13G | armistice-eras123123.htm | 0001172661-24-001348 | 005-92728 | 24636929 | 34 | 90654 | |||
| 2024-02-13 | SC 13G/A | SC 13G/A | 0001193125-24-034344 | 005-92728 | 24631399 | 34 | 71755 | |||
| 2024-02-07 | 4 | FORM 4 SUBMISSION | 0001209191-24-002968 | 5562 | ||||||
| 2024-02-07 | 4 | FORM 4 SUBMISSION | 0001209191-24-002967 | 5493 | ||||||
| 2024-02-07 | 4 | FORM 4 SUBMISSION | 0001209191-24-002966 | 5490 | ||||||
| 2024-02-07 | 4 | FORM 4 SUBMISSION | 0001209191-24-002965 | 5498 | ||||||
| 2024-01-30 | SC 13D/A | AMENDMENT NO. 3 | 0000929638-24-000306 | 005-92728 | 24578774 | 34 | 96432 | |||
| 2024-01-16 | 144 | xsl144X01/primary_doc.xml | 0001971857-24-000070 | 001-40602 | 24534580 | 33 | 6291 | |||
| 2024-01-09 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-003199 | 001-40602 | 24521900 | 34 | 24751793 | 1 | 1 |
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000272 | 5811 | ||||||
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000271 | 5818 | ||||||
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000270 | 5745 | ||||||
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000269 | 5814 | ||||||
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000268 | 5807 | ||||||
| 2023-12-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-058912 | 4946 | ||||||
| 2023-12-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-058910 | 4941 | ||||||
| 2023-12-15 | 144 | xsl144X01/primary_doc.xml | 0002002698-23-000116 | 001-40602 | 231489672 | 33 | 6210 | |||
| 2023-12-11 | 8-K | 8-K | 8.01 | 0000950170-23-069212 | 001-40602 | 231477072 | 34 | 159174 | 1 | 1 |
| 2023-12-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-057833 | 5508 | ||||||
| 2023-12-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-057681 | 8241 | ||||||
| 2023-12-04 | 4 | FORM 4 SUBMISSION | 0001209191-23-057297 | 5173 | ||||||
| 2023-11-28 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-066250 | 001-40602 | 231442138 | 34 | 555938 | 1 | 1 |
| 2023-11-15 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000859 | 001-40602 | 231409690 | 33 | 6211 | |||
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-062094 | 001-40602 | 231392797 | 34 | 10662665 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-062003 | 001-40602 | 231392249 | 34 | 341040 | 1 | 1 |
| 2023-10-16 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000752 | 001-40602 | 231326835 | 33 | 6208 | |||
| 2023-10-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-052403 | 6325 | ||||||
| 2023-09-15 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000680 | 001-40602 | 231258331 | 33 | 6255 | |||
| 2023-08-29 | 8-K | 8-K | 8.01 | 0000950170-23-045056 | 001-40602 | 231221941 | 34 | 175055 | 1 | 1 |
| 2023-08-15 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000530 | 001-40602 | 231174243 | 33 | 6250 | |||
| 2023-08-10 | 10-Q | 10-Q | 0000950170-23-041333 | 001-40602 | 231159532 | 34 | 11943161 | 1 | 1 | |
| 2023-08-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-041299 | 001-40602 | 231159298 | 34 | 392675 | 1 | 1 |
| 2023-07-17 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000393 | 001-40602 | 231090965 | 33 | 6202 | |||
| 2023-06-27 | 8-K | 8-K | 5.07 | 0000950170-23-030108 | 001-40602 | 231047341 | 34 | 205806 | 1 | 1 |
| 2023-06-26 | 4 | xslF345X04/form4.xml | 0000929638-23-001787 | 14655 | ||||||
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039589 | 5372 | ||||||
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039588 | 5378 | ||||||
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039587 | 5208 | ||||||
| 2023-06-26 | 4/A | FORM 4/A SUBMISSION | 0001209191-23-039586 | 5116 | ||||||
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039585 | 5374 | ||||||
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039584 | 5374 | ||||||
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039583 | 5367 | ||||||
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039582 | 5371 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035590 | 6323 | ||||||
| 2023-06-05 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-026427 | 001-40602 | 23993631 | 34 | 20445676 | 1 | 1 |
| 2023-05-25 | 8-K | 8-K | 8.01 | 0000950170-23-024292 | 001-40602 | 23961947 | 34 | 181713 | 1 | 1 |
| 2023-05-15 | 10-Q | 10-Q | 0000950170-23-022282 | 001-40602 | 23924159 | 34 | 12643313 | 1 | 1 | |
| 2023-05-15 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-022194 | 001-40602 | 23922098 | 34 | 348233 | 1 | 1 |
| 2023-05-01 | ARS | ARS | 0001193125-23-127932 | 001-40602 | 23869263 | 34 | 16673589 | |||
| 2023-04-28 | DEFA14A | DEFA14A | 0001193125-23-127078 | 001-40602 | 23866812 | 34 | 43359 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0001193125-23-127025 | 001-40602 | 23866565 | 34 | 533330 | |||
| 2023-04-19 | 8-K | 8-K | 8.01 | 0000950170-23-013370 | 001-40602 | 23828579 | 34 | 177307 | 1 | 1 |
| 2023-04-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-024257 | 5384 | ||||||
| 2023-04-13 | 3 | FORM 3 SUBMISSION | 0001209191-23-024255 | 5494 | ||||||
| 2023-04-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-023955 | 5172 | ||||||
| 2023-04-10 | 8-K | 8-K | 5.02 | 0000950170-23-012240 | 001-40602 | 23809787 | 34 | 180331 | 1 | 1 |
| 2023-03-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-021458 | 6322 | ||||||
| 2023-03-23 | 10-K | 10-K | 0000950170-23-009496 | 001-40602 | 23756396 | 34 | 114617683 | 1 | 1 | |
| 2023-03-23 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-009478 | 001-40602 | 23756244 | 34 | 419748 | 1 | 1 |
| 2023-03-10 | SC 13G/A | filing.txt | 0000315066-23-002204 | 005-92728 | 23721863 | 34 | 8043 | |||
| 2023-02-15 | 5 | FORM 5 SUBMISSION | 0000899243-23-005182 | 6709 | ||||||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-039199 | 005-92728 | 23629730 | 34 | 73565 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021581 | 005-92728 | 23628983 | 34 | 126195 | |||
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001612 | 005-92728 | 23602300 | 34 | 8028 | |||
| 2023-02-09 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-028869 | 001-40602 | 23600873 | 34 | 621488 | 1 | 1 |
| 2023-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-006482 | 5432 | ||||||
| 2023-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-006481 | 8767 | ||||||
| 2023-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-006480 | 8749 | ||||||
| 2023-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-006479 | 8748 | ||||||
| 2023-01-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-002802 | 6290 | ||||||
| 2023-01-09 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-004264 | 001-40602 | 23516859 | 34 | 34156917 | 1 | 1 |
| 2022-12-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-062537 | 5475 | ||||||
| 2022-12-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-062536 | 5716 | ||||||
| 2022-12-21 | 4/A | xslF345X03/form4.xml | 0000929638-22-001904 | 13646 | ||||||
| 2022-12-21 | SC 13D/A | cormorant_sc13d.htm | 0000929638-22-001903 | 005-92728 | 221478805 | 34 | 90305 | |||
| 2022-12-20 | 4 | xslF345X03/form4.xml | 0000929638-22-001901 | 13308 | ||||||
| 2022-12-19 | SC 13G | SC 13G | 0001104659-22-128252 | 005-92728 | 221471368 | 34 | 109617 | |||
| 2022-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-061461 | 5141 | ||||||
| 2022-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-061352 | 6290 | ||||||
| 2022-12-09 | 8-K | 8-K | 3.02,8.01,9.01 | 0001193125-22-301902 | 001-40602 | 221455715 | 34 | 468437 | 1 | 1 |
| 2022-12-09 | 424B5 | 424B5 | 0001193125-22-301897 | 333-266802 | 221455679 | 33 | 426009 | |||
| 2022-12-09 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-22-301402 | 001-40602 | 221453643 | 34 | 39914437 | 1 | 1 |
| 2022-11-09 | 10-Q | 10-Q | 0000950170-22-023926 | 001-40602 | 221373190 | 34 | 11799211 | 1 | 1 | |
| 2022-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-023851 | 001-40602 | 221372657 | 34 | 419543 | 1 | 1 |
| 2022-09-07 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-240127 | 001-40602 | 221231903 | 34 | 31034093 | 1 | 1 |
| 2022-09-06 | SC 13G | SC 13G | 0001104659-22-097847 | 005-92728 | 221228250 | 34 | 137729 | |||
| 2022-08-18 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-08-18 16:00:00 | 9999999995-22-002436 | 333-266802 | 221178844 | 33 | 1676 | ||
| 2022-08-16 | CORRESP | filename1.htm | 0001193125-22-222335 | 6609 | ||||||
| 2022-08-15 | UPLOAD | filename1.pdf | 0000000000-22-008665 | 40093 | ||||||
| 2022-08-11 | S-3 | S-3 | 0001193125-22-218726 | 333-266802 | 221156993 | 33 | 1017024 | |||
| 2022-08-11 | 10-Q | 10-Q | 0000950170-22-016907 | 001-40602 | 221156265 | 34 | 10967996 | 1 | 1 | |
| 2022-08-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-016874 | 001-40602 | 221155984 | 34 | 397697 | 1 | 1 |
| 2022-07-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-041388 | 7023 | ||||||
| 2022-06-24 | 4 | FORM 4 | 0001567619-22-013362 | 8517 | ||||||
| 2022-06-24 | 8-K | 8-K | 5.07 | 0000950170-22-012066 | 001-40602 | 221037294 | 34 | 202948 | 1 | 1 |
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-039106 | 5340 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-039105 | 5346 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-039104 | 5342 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-039103 | 5342 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-039102 | 5335 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-039101 | 5339 | ||||||
| 2022-05-12 | 10-Q | 10-Q | 0000950170-22-009720 | 001-40602 | 22918432 | 34 | 12478427 | 1 | 1 | |
| 2022-05-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-009671 | 001-40602 | 22917936 | 34 | 331535 | 1 | 1 |
| 2022-04-28 | DEFA14A | DEFA14A | 0001193125-22-127631 | 001-40602 | 22866879 | 34 | 640093 | |||
| 2022-04-28 | DEF 14A | DEF 14A | 0001193125-22-127567 | 001-40602 | 22866674 | 34 | 1052211 | |||
| 2022-04-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-025841 | 5223 | ||||||
| 2022-04-27 | 3 | FORM 3 SUBMISSION | 0001209191-22-025833 | 7427 | ||||||
| 2022-04-27 | 8-K | 8-K | 5.02 | 0000950170-22-006366 | 001-40602 | 22859501 | 34 | 207838 | 1 | 1 |
| 2022-03-24 | 10-K | 10-K | 0000950170-22-004557 | 001-40602 | 22766800 | 34 | 70810129 | 1 | 1 | |
| 2022-03-24 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-004546 | 001-40602 | 22766600 | 34 | 389954 | 1 | 1 |
| 2022-03-18 | SC 13G | SC 13G | 0001654954-22-003451 | 005-92728 | 22753267 | 34 | 111180 | |||
| 2022-02-14 | SC 13G | SC 13G | 0001193125-22-037531 | 005-92728 | 22623327 | 34 | 78631 | |||
| 2022-02-10 | SC 13G | ARCH VENTURE FUND X, L.P. - ERASCA, INC. -- SCH 13G | 0001072613-22-000078 | 005-92728 | 22615110 | 34 | 292495 | |||
| 2022-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-007069 | 7126 | ||||||
| 2022-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-007065 | 7128 | ||||||
| 2022-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-007062 | 5436 | ||||||
| 2022-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-007054 | 7146 | ||||||
| 2022-01-10 | SC 13G | filing.txt | 0000315066-22-000042 | 005-92728 | 22520722 | 34 | 8372 | |||
| 2021-11-23 | 8-K | 8-K | 1.01 | 0000950170-21-004876 | 001-40602 | 211439635 | 34 | 166799 | 1 | 1 |
| 2021-11-10 | 10-Q | 10-Q | 0000950170-21-004131 | 001-40602 | 211397317 | 34 | 11594977 | 1 | 1 | |
| 2021-11-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-004113 | 001-40602 | 211397076 | 34 | 379223 | 1 | 1 |
| 2021-08-26 | 10-Q | 10-Q | 0000950170-21-001573 | 001-40602 | 211213001 | 34 | 11551789 | 1 | 1 | |
| 2021-08-26 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-257579 | 001-40602 | 211212490 | 34 | 74946 | ||
| 2021-08-10 | 4 | FORM 4 | 0001567619-21-014882 | 10092 | ||||||
| 2021-08-10 | SC 13D/A | cormorant_sc13d.htm | 0000929638-21-000990 | 005-92728 | 211159810 | 34 | 89719 | |||
| 2021-07-30 | SC 13D | cormorant_sc13d.htm | 0000929638-21-000959 | 005-92728 | 211132396 | 34 | 115170 | |||
| 2021-07-22 | 4 | FORM 4 | 0001567619-21-013838 | 22558 | ||||||
| 2021-07-20 | 4 | FORM 4 SUBMISSION | 0000899243-21-029085 | 19667 | ||||||
| 2021-07-20 | 4 | FORM 4 SUBMISSION | 0000899243-21-029084 | 4482 | ||||||
| 2021-07-20 | 4 | FORM 4 SUBMISSION | 0000899243-21-029082 | 11494 | ||||||
| 2021-07-20 | 4 | FORM 4 SUBMISSION | 0000899243-21-029077 | 34927 | ||||||
| 2021-07-20 | 4 | FORM 4 SUBMISSION | 0000899243-21-029068 | 4464 | ||||||
| 2021-07-20 | 4 | FORM 4 SUBMISSION | 0000899243-21-029060 | 4470 | ||||||
| 2021-07-20 | 4 | FORM 4 SUBMISSION | 0000899243-21-029053 | 4464 | ||||||
| 2021-07-20 | 8-K | 8-K | 5.03,8.01,9.01 | 0001193125-21-219642 | 001-40602 | 211101293 | 34 | 245391 | ||
| 2021-07-16 | 3/A | FORM 3/A | 0001567619-21-013592 | 10128 | ||||||
| 2021-07-16 | S-8 | S-8 | 0001193125-21-217570 | 333-257988 | 211096237 | 33 | 98331 | |||
| 2021-07-16 | 424B4 | 424B4 | 0001193125-21-217534 | 333-257436 | 211096102 | 33 | 13000926 | |||
| 2021-07-15 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-07-15 16:00:00 | 9999999995-21-002792 | 333-257436 | 211094197 | 33 | 1676 | ||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028587 | 10076 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028586 | 9393 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028585 | 11845 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028581 | 10169 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028580 | 8894 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028579 | 13666 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028573 | 29530 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028572 | 10481 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028571 | 12055 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028567 | 9384 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028563 | 24925 | ||||||
| 2021-07-15 | S-1MEF | S-1MEF | 0001193125-21-216695 | 333-257937 | 211093897 | 33 | 41714 | |||
| 2021-07-15 | 3 | FORM 3 | 0001567619-21-013499 | 14140 | ||||||
| 2021-07-15 | CERT | 8ACERT_ERAS.pdf | 0001354457-21-000794 | 001-40602 | 211091904 | 34 | 161325 | |||
| 2021-07-13 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-004099 | 271766 | ||||||
| 2021-07-13 | 8-A12B | 8-A12B | 0001193125-21-214084 | 001-40602 | 211087920 | 34 | 13744 | |||
| 2021-07-13 | CORRESP | filename1.htm | 0001193125-21-214077 | 11468 | ||||||
| 2021-07-13 | CORRESP | filename1.htm | 0001193125-21-214069 | 7909 | ||||||
| 2021-07-12 | CORRESP | filename1.htm | 0001193125-21-212365 | 27251 | ||||||
| 2021-07-12 | S-1/A | S-1/A | 0001193125-21-212361 | 333-257436 | 211084186 | 33 | 14223173 | |||
| 2021-07-09 | UPLOAD | filename1.pdf | 0000000000-21-008531 | 47257 | ||||||
| 2021-06-28 | CORRESP | filename1.htm | 0001193125-21-201587 | 108284 | ||||||
| 2021-06-25 | CORRESP | filename1.htm | 0001193125-21-200549 | 44712 | ||||||
| 2021-06-25 | S-1 | S-1 | 0001193125-21-200537 | 333-257436 | 211048836 | 33 | 17529554 | |||
| 2021-06-21 | UPLOAD | filename1.pdf | 0000000000-21-007562 | 49875 | ||||||
| 2021-06-09 | DRSLTR | filename1.htm | 0000950123-21-007701 | 53590 | ||||||
| 2021-06-09 | DRS/A | filename1.htm | 0000950123-21-007700 | 377-04809 | 211006022 | 33 | 13031887 | |||
| 2021-06-02 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-003324 | 272587 | ||||||
| 2021-06-02 | UPLOAD | filename1.pdf | 0000000000-21-006819 | 56750 | ||||||
| 2021-05-07 | DRS | filename1.htm | 0000950123-21-005597 | 377-04809 | 21903930 | 33 | 15221075 | |||
| 2020-04-30 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-20-008665 | 021-366079 | 20835071 | 33 | 9364 | ||
| 2019-03-11 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001567619-19-006548 | 021-330625 | 19672156 | 33 | 9484 | ||
| 2019-01-15 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-19-001152 | 021-330625 | 19527252 | 33 | 8628 |
One latest value per concept from companyfacts (205 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 350.96M | 2026-11-05 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 316.40M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 15,579.29 | 2026-08-10 | S-8 | 2026-08-11 | 0001193125-26-344845 | |||
| ffd | NrrtvMaxAggtOfferingPric | NrrtvMaxAggtOfferingPric | USD | 632.50M | 2026-07-14 | 424B5 | 2026-07-14 | 0001193125-26-303352 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 15,579.29 | 2026-08-10 | S-8 | 2026-08-11 | 0001193125-26-344845 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 112.81M | 2026-08-10 | S-8 | 2026-08-11 | 0001193125-26-344845 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-10 | S-8 | 2026-08-11 | 0001193125-26-344845 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-07-14 | 424B5 | 2026-07-14 | 0001193125-26-303352 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 3.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 3.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 10.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 34.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 261,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 14.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -4.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 2.09B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 11.93M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 30.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 58.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | Assets | Assets | USD | 998.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 655.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 5,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 4.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 833.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 828.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 118.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 947.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 119.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 119.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 45.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 81.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | CommonStockDividendsPerShareDeclared | Common Stock, Dividends, Per Share, Declared | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 800.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 350.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 350.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 35,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -283.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 340.80M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009496 |
| us-gaap | DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent | Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Current | USD | 5.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 14.98M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125481 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 4,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125481 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | Position | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 813.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 4.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 813.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 4.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | Position | 114 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 11.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009496 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 32.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 253.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 127.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 3.49M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 23.91M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 10.17M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 242.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 3.17M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 857,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 0.03 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 2.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.87 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.31 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009720 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.87 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.196 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.016 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.006 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-20 | 0000950170-25-042682 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.027 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 6.31M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-26 | 0000950170-21-001573 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | FederalIncomeTaxExpenseBenefitContinuingOperations | Federal Income Tax Expense (Benefit), Continuing Operations | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | FinancialLiabilitiesFairValueDisclosure | Financial Liabilities Fair Value Disclosure | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0000950170-22-004557 | |
| us-gaap | ForeignIncomeTaxExpenseBenefitContinuingOperations | Foreign Income Tax Expense (Benefit), Continuing Operations | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 34.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-037193 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -124.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -124.55M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | -51,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 72,000 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-26 | 0000950170-21-001573 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 24.35M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | -2,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -26.16M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 433,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.99M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 672,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 3.42M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 2.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 16.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | LandSubjectToGroundLeases | Land Subject to Ground Leases | sqft | 16,153 | 2018-12-31 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004131 | |
| us-gaap | LeaseCost | Lease, Cost | USD | 6.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 55.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 15.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 9.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 9.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 9.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 9.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 9.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 2.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 12.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | Liabilities | Liabilities | USD | 82.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 998.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 43.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 44.77M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0000950170-22-004557 | |
| us-gaap | LossContingencyAccrualAtCarryingValue | Loss Contingency Accrual | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | LossContingencyNumberOfPlaintiffs | Loss Contingency, Number of Plaintiffs | Litigation | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0000950170-22-004557 |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 524.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 304.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss | USD | 47,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 845.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -712.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -87.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -278.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 16.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-037193 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 295.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -295.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 5.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 43.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 5.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 37.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 4.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 26.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.09 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 396,000 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-12 | 0000950170-24-095437 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 1.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -4.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -2.94M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 392,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 115,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 22,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001193125-26-216788 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 54.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | PaymentsToAcquireEquitySecuritiesFvNi | PaymentsToAcquireEquitySecuritiesFvNi | USD | 157,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | PaymentsToAcquireInProcessResearchAndDevelopment | Payments to Acquire in Process Research and Development | USD | 150.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 105.81M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0000950170-22-004557 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 778.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 123,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 80.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 11.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 317.00M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009496 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 891.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 119.39M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009496 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 43.60M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 114.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 261.03M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 60.11M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0000950170-22-004557 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 100.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 8.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -278.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 26.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 11.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 110.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 2.00M | 2022-01-01 | 2022-06-30 | 2023 | Q2 | 10-Q | 2023-08-10 | 0000950170-23-041333 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 408,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 408,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.17B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 22.70M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-037193 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 30.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009720 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.86 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009720 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.859 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009720 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.017 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009720 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.015 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009720 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 0 | 2020-04-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-26 | 0000950170-21-001573 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 91,144 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009720 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 53.99M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-24 | 0000950170-22-004557 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-037193 |
| us-gaap | StateAndLocalIncomeTaxExpenseBenefitContinuingOperations | State and Local Income Tax Expense (Benefit), Continuing Operations | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 916.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 1.2 | 2021-07-09 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009496 | |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 1.68M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009496 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 340.80M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009496 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 769,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 3.65M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 2.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-26 | 0000950170-21-001573 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 97.62M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-26 | 0000950170-21-001573 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 6.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 862,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 99,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-037193 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 6.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 62.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-104150 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 2.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 320.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 119.49M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009720 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 320.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458289 |